With treatment, clinical indicators of nephrotic syndrome improved since serum albumin increased from 19.8 to 29.1 g/L and urine protein declined from 1.76 to 1.17 g/L over the initial three cycles. This evidence concerns the gene ALB and nephrotic syndrome.